LIFEVANTAGE CORP (LFVN) Operating Margin
- Operating margin · 12 months: Value 3.34%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 3.34% | Operating income / revenue. Period ending 2026-06-30. $6.10M ÷ $182.59M × 100 ≈ 3.34% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 6.10M USD | Operating Income (Loss) |
| Revenue | 182.59M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 40.97M USD | Cost of Goods and Services Sold |
| Research and development | 1.00M USD | Research and Development Expense |
| Selling, general and administration | 58.42M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6.10M | $182.59M | $40.97M | $1.00M | $58.42M | 3.34% |
| 2026-03-31 | $6.58M | $195.32M | $42.70M | $1.20M | $63.23M | 3.37% |
| 2025-12-31 | $8.96M | $210.05M | $44.65M | $1.50M | $66.42M | 4.26% |
| 2025-09-30 | $11.90M | $228.88M | $45.12M | $1.40M | $69.21M | 5.20% |
| 2025-06-30 | $12.20M | $228.53M | $44.86M | $1.40M | $69.21M | 5.34% |
| 2025-03-31 | $12.96M | $222.35M | $43.82M | $1.20M | $64.55M | 5.83% |
| 2024-12-31 | $10.84M | $212.15M | $42.88M | $900.00K | $63.91M | 5.11% |
| 2024-09-30 | $6.15M | $196.01M | $40.75M | $800.00K | $65.36M | 3.14% |
| 2024-06-30 | $4.33M | $200.16M | $41.44M | $700.00K | $68.47M | 2.16% |
| 2024-03-31 | $4.03M | $205.45M | $42.49M | $700.00K | $71.50M | 1.96% |
| 2023-12-31 | $3.69M | $210.95M | $42.93M | $600.00K | $72.78M | 1.75% |
| 2023-09-30 | $3.72M | $212.99M | $43.63M | $700.00K | $72.30M | 1.75% |
| 2023-06-30 | $4.26M | $213.40M | $43.39M | $600.00K | $71.06M | 2.00% |
| 2023-03-31 | $3.15M | $210.12M | $41.65M | $500.00K | $69.63M | 1.50% |
| 2022-12-31 | $3.38M | $206.38M | $40.69M | $600.00K | $67.24M | 1.64% |
| 2022-09-30 | $4.25M | $204.91M | $38.61M | $600.00K | $65.08M | 2.08% |
| 2022-06-30 | $7.58M | $206.36M | $38.10M | $700.00K | $63.42M | 3.67% |
| 2022-03-31 | $12.66M | $210.19M | $38.55M | $700.00K | $60.62M | 6.02% |
| 2021-12-31 | $12.92M | $211.76M | $37.71M | $700.00K | $60.82M | 6.10% |
| 2021-09-30 | $18.73M | $218.58M | $38.22M | $700.00K | $59.62M | 8.57% |
| 2021-06-30 | $17.61M | $220.18M | $38.19M | $700.00K | $60.84M | 8.00% |
| 2021-03-31 | $17.24M | $224.77M | $37.85M | $700.00K | $62.84M | 7.67% |
| 2020-12-31 | $18.19M | $229.28M | $38.13M | $800.00K | $64.61M | 7.93% |
| 2020-09-30 | $16.39M | $231.51M | $38.17M | $900.00K | $66.53M | 7.08% |
| 2020-06-30 | $15.47M | $232.91M | $37.96M | $900.00K | $67.91M | 6.64% |
| 2020-03-31 | $14.93M | $229.72M | $38.23M | $900.00K | $68.44M | 6.50% |
| 2019-12-31 | $14.13M | $229.65M | $38.40M | $700.00K | $68.45M | 6.15% |
| 2019-09-30 | $11.07M | $226.58M | $37.96M | $900.00K | $69.94M | 4.88% |
| 2019-06-30 | $9.81M | $225.96M | $37.97M | $1.10M | $69.55M | 4.34% |
| 2019-03-31 | $8.45M | $223.82M | $36.33M | $1.40M | $68.81M | 3.77% |
| 2018-12-31 | $8.50M | $218.37M | $35.99M | $1.60M | $66.53M | 3.89% |
| 2018-09-30 | $10.25M | $209.69M | $35.31M | $1.30M | $61.56M | 4.89% |
| 2018-06-30 | $10.32M | $203.20M | $34.85M | $1.20M | $59.84M | 5.08% |
| 2018-03-31 | $7.56M | $199.81M | $35.67M | $1.10M | $61.47M | 3.79% |
| 2017-12-31 | $5.49M | $194.26M | $34.98M | $1.00M | $60.16M | 2.83% |
| 2017-09-30 | $3.86M | $193.72M | $33.36M | $1.10M | $62.72M | 1.99% |
| 2017-06-30 | $4.45M | $199.49M | $33.46M | $1.10M | $64.92M | 2.23% |
| 2017-03-31 | $6.99M | $201.88M | $33.97M | $1.10M | $62.65M | 3.46% |
| 2016-12-31 | $10.40M | $213.03M | $35.45M | $1.10M | $63.57M | 4.88% |
| 2016-09-30 | $12.73M | $216.08M | $35.79M | $1.10M | $60.19M | 5.89% |
| 2016-06-30 | $13.41M | $206.54M | $33.93M | $1.00M | $56.07M | 6.49% |
| 2016-03-31 | $10.89M | $198.81M | $31.82M | $1.30M | $56.90M | 5.48% |
| 2015-12-31 | $8.75M | $187.80M | $29.66M | $1.70M | $56.75M | 4.66% |
| 2015-09-30 | $8.80M | $184.06M | $29.31M | $2.10M | $57.40M | 4.78% |
| 2015-06-30 | $13.90M | $190.34M | $28.01M | $2.40M | $57.35M | 7.30% |
| 2015-03-31 | $17.09M | $201.07M | $29.70M | $2.30M | $57.92M | 8.50% |
| 2014-12-31 | $20.07M | $210.98M | $30.61M | $2.30M | $58.81M | 9.51% |
| 2014-09-30 | $22.14M | $214.27M | $31.06M | $2.20M | $57.37M | 10.33% |
| 2014-06-30 | $19.45M | $213.97M | $33.19M | $2.00M | $56.80M | 9.09% |
| 2014-03-31 | $14.95M | $209.44M | $32.12M | $2.39M | (m) | 7.14% |
| 2013-12-31 | $14.97M | $204.75M | $30.99M | $2.58M | (m) | 7.31% |
| 2013-09-30 | $10.23M | $206.65M | $31.85M | $2.74M | (m) | 4.95% |
| 2013-06-30 | $12.07M | $208.18M | $31.84M | $2.95M | (m) | 5.80% |
| 2013-03-31 | $19.16M | $201.27M | $30.36M | $2.54M | (m) | 9.52% |
| 2012-12-31 | $21.08M | $187.11M | $28.02M | $2.07M | (m) | 11.27% |
| 2012-09-30 | $24.93M | $158.96M | $22.90M | $1.64M | (m) | 15.69% |
| 2012-06-30 | $21.46M | $126.18M | $18.05M | $1.36M | (m) | 17.00% |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $3.70M | $38.92M | $5.92M | $508.60K | (m) | 9.51% |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |